Vaccinating a person throughout his life costs the National Health System an average of between 600 and 700 euros and a vulnerable person, depending on their medical circumstances, around 1,500, so that vaccines are the best prevention tool against any disease by reducing health costs and promoting social equity, as the antidotes against covid-19 have shown.
It is the premise on which various experts have agreed during a scientific session organized this week by the Royal National Academy of Medicine (RANME), on the occasion of the European Vaccination Week and in which the antidotes against covid-19 have had a special role.
According to RANME data, vaccinating a woman throughout her life is around 600 euros and a man 700, while that amount doubles when it comes to groups with greater vulnerability, while highlighting that it is one of the main weapons of the national health system against a wide range of viral diseases, some of which have already been eradicated, such as smallpox (1979).
At the meeting, the experts have made a historical review of the genesis that has led to the creation of a large part of the modern vaccines that are dispensed today, up to the antidotes that have served in these two years to fight against the pandemic. As for the merely economic impact of vaccines, without detailing benefits that are far above such as human, social and health, all analyzes on “the cost-benefit ratio” point to savings, although this amount is difficult to estimate , according to experts.
In this sense, Jesús Ruiz Contreras, head of the Pediatric Service of the 12 October University Hospital in Madrid, highlighted that vaccines prevent bacterial resistance and even cancer, while eradicating diseases, favoring group immunity, reducing hospitalization rates and propitiate that, in case of infection, the disease is more benign.
Reducing deaths, hospitalizations and promoting mild symptoms has been the main role of the current vaccines against covid-19 -both messenger RNA and those based on adenoviruses-, said José Gómez Rial, immunologist at the Galician Health Service of the Hospital University of Santiago de Compostela, who has opposed this question against the erroneous thought that they were going to be sterilizing to avoid infection by covid-19.
He lamented that at the beginning of the massive vaccination campaigns against Sars-CoV-2 it was ensured that they would favor sterilizing and group immunity, something for which they were not designed and that will only be achieved when intranasal antidotes are authorized, he recalled.
There are several intranasal vaccines under development in the world, including that of the CSIC and whose managers have assured that it could see the light of day at the end of 2022, given that to achieve total immunity against covid-19 it is necessary to sterilize the mucous membranes, the main Sars-Cov-2 entry bridge in the body.
The role of the Public Health Commission and the Vaccine Report during the pandemic has also been valued, as well as the more than 50 meetings to advise on the different phases and strategies of vaccination, explained the head of the Programs Area of the General Subdirectorate for Health Promotion and Prevention of the Ministry of Health, Aurora Limia.
Limia has stressed that the communities and Health are working on a universal vaccination registry, fostered by the systems and experiences of the massive campaign against the pandemic, so that any professional – public, private or from an international medical organization – can access the data of vaccination of each patient.
An initiative that will result, in his opinion, in a benefit to the public health strategy of Spain, since each citizen will be able to know from that moment if they have received the vaccines recommended in the calendar and that they protect against at least 14 diseases.